A case-control study of risk factors for intussusception among infants in eastern France after the introduction of the rotavirus vaccine.
Breast Feeding
/ methods
Case-Control Studies
Female
France
Gastroenteritis
/ chemically induced
Hospitalization
Humans
Infant
Infant, Newborn
Intussusception
/ chemically induced
Male
Odds Ratio
Risk Factors
Rotavirus
/ immunology
Rotavirus Infections
/ immunology
Rotavirus Vaccines
/ adverse effects
Vaccination
/ adverse effects
Vaccines, Attenuated
/ adverse effects
Case-control study- rotavirus vaccine
Infants
Intussusception
Risk factors
Journal
Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899
Informations de publication
Date de publication:
26 07 2019
26 07 2019
Historique:
received:
11
04
2018
revised:
31
01
2019
accepted:
14
02
2019
pubmed:
11
3
2019
medline:
17
9
2020
entrez:
11
3
2019
Statut:
ppublish
Résumé
The objective of the present study was to investigate the risk factors for intussusception (IS) among infants, including vaccination against rotavirus. Case-control study with systematic inclusion of all infants aged <1 year with suspected IS admitted to emergency departments in the eastern region of France between 1 April 2008 and 31 March 2012. All cases classed level 1 according to the Brighton classification were matched to 4 hospital controls. Two exposure windows were examined; exposure to the first dose of rotavirus vaccine in the 7 and in the 14 days prior to the occurrence of IS. A total of 115 cases were matched with 457 controls. The average vaccination coverage rate over the 4 years of study was 8.6%. Rotavirus vaccine was not found to be significantly associated with the occurrence of IS in the 7 days (odds ratio (OR) not calculated; p = 0.99) and in the 14 days after administration of one dose vaccine (OR 1.33, 95% confidence interval (CI) 0.14-12.82). Infant formula alone or combined with breastfeeding was associated with an excess risk of IS (OR 2.74, 95% CI 1.10-6.79). A history of gastroenteritis within 2 weeks prior to hospitalisation was also associated with an increased risk (OR 2.24, 95% CI 1.07-4.67). Our study indicates that infant formula alone or combined with breastfeeding is a risk factor for IS. A small, non-significant increase in the risk of IS was observed after rotavirus vaccination, although the low vaccine coverage rate likely precluded detection of a significant increase in risk.
Identifiants
pubmed: 30851968
pii: S0264-410X(19)30260-9
doi: 10.1016/j.vaccine.2019.02.053
pii:
doi:
Substances chimiques
Rotavirus Vaccines
0
Vaccines, Attenuated
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4587-4593Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.